S23-287 Using de novo protein design to target MHC-1 and MR-1 antigens Stanford scientists have created a de novo protein design platform that designs binding proteins that specifically target antigens in the major histocompatibility complex (MHC). Possu Huang Haotian Du Nikolaos Sgourakis Leena Mallik
S22-077 Optimizing clonal expansion of CD8 T cells by using silent mutations Stanford scientists have discovered that using silent mutations to alter codon:anticodon affinity can be used to tune clonal expansion in CD8 T cells. Ansuman Satpathy Caleb Lareau